Trial | NCT00303017  Report issue

Title

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study
Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    60
safety, efficacy and acceptability of Flavocoxid
Safety, Efficacy and acceptability of Flavocoxid (Limbrel) compared with Naproxen in Subjects with Osteoarthritis of the Knee. A Pilot Study
Study Started
Mar 31
2006
Primary Completion
Jul 31
2006
Study Completion
Sep 30
2006
Last Update
Oct 21
2015
Estimate

Dietary Supplement flavocoxid

flavonoid mixture

  • Other names: Limbrel

Drug Naproxen

non-steroidal anti-inflammatory drug

  • Other names: naprosyn

flavocoxid Experimental

medical food

naproxen Active Comparator

NSAID

Criteria 

Inclusion Criteria:

OA of the knee,K-L grade 2-3 in general good health is currently taking an NSAID or COX-2 inhibitor -

Exclusion Criteria:

pregant or nursing women grade 1 or 4 OA any significant medical condition that in the opinion of the physician might put the subject at risk in this study any form of arthropathy other than OA any condition that might confound the evaluation of the pain, stiffness or function of the target joint intra-articular cotticosteroid inkection in the target joint within 3 month of the screening visit concomitant use of other anti-inflammatory or anti arthritic medication or products(including OTC and herbal preparations) Low dose aspirin for cardio-protection is allowed concomitant use of coumadin or other anticoagulant or anti-platelet medication concomitant use of gastro-protectiv medications including, but not limited to, H2 blockers and proton pump inhibitors, including OTC and herbal products History of allergy to Flavonoids

-
No Results Posted